The purpose of this study is to determine if Bone Marrow Concentrate may be successful in the treatment of osteoarthritis. Bone Marrow Concentrate is known to contain a community of cells that has been shown to have "regenerative" properties. This study is designed to evaluate the short-term clinical and x-ray outcomes of injections for hip and knee osteoarthritis. Inclusion Criteria: * Subjects must be scheduled for an autologous bone marrow hip or knee injection * Subjects must have a diagnosis of hip or knee osteoarthritis * Subjects must be between the ages of 18 and 85 * Subjects must be willing and able to sign Informed Consent * Subjects must be willing and able to return for scheduled follow-up evaluations Exclusion Criteria: * Subjects who have had any type of visco-supplementation in the treated joint within the last three months prior to enrollment * Subjects for whom baseline data is not available
Study Type
OBSERVATIONAL
Enrollment
12
This is strictly data collection and outcomes based. The procedure is not part of this study
Regenerative Pain Center
Des Plaines, Illinois, United States
Visual Analog Pain Scale
Change in subjective pain measure
Time frame: Baseline, 6 weeks, 3 months, 1 year
Harris Hip Score or Knee Society Score
Change in subjective pain, function, functional activity measurement and a clinical physical exam
Time frame: Baeline, 6 weeks, 3 months, 1 year
Physician Global Assessment
Change in physician rated disease activity measurement
Time frame: Baseline, 6 weeks, 3 months, 1 year
Radiologic
Radiographic changes of the hip or knee
Time frame: Baseline, 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.